Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bayliss

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Hepatology (Baltimore, Md.)|July 1, 1999
Methods in outcomes research in hepatology: definitions and domains of quality of lifeM S Bayliss
Medical Device Technology|August 8, 2001
Semiconducting biomaterials: current status and future perspectivesL Buckberry, S Bayliss
Health Technology Assessment (Winchester, England)|February 2, 2011
Palivizumab for immunoprophylaxis of respiratory syncytial virus (RSV) bronchiolitis in high-risk infants and young children: a systematic review and additional economic modelling of subgroup analysesD Wang, S Bayliss, C Meads
Health Technology Assessment (Winchester, England)|June 15, 2004
Clinical effectiveness and cost-effectiveness of prehospital intravenous fluids in trauma patientsJ Dretzke, J Sandercock, S Bayliss, et al.
Health and Quality of Life Outcomes|July 8, 2009
The impact of itch symptoms in psoriasis: results from physician interviews and patient focus groupsDenise Globe, Martha S Bayliss, David J Harrison
Health Technology Assessment (Winchester, England)|December 4, 2008
Immunoprophylaxis against respiratory syncytial virus (RSV) with palivizumab in children: a systematic review and economic evaluationD Wang, C Cummins, S Bayliss, et al.
Hepatology (Baltimore, Md.)|July 27, 1999
Health-related quality of life in chronic hepatitis C: impact of disease and treatment response. The Interventional Therapy GroupJ E Ware, M S Bayliss, M Mannocchia, et al.
Seminars in Liver Disease|June 1, 1999
Sustained virologic response is associated with improved health-related quality of life in relapsed chronic hepatitis C patientsM P Neary, S Cort, M S Bayliss, et al.
Health and Quality of Life Outcomes|September 9, 2004
Predicting declines in physical function in persons with multiple chronic medical conditions: what we can learn from the medical problem listElizabeth A Bayliss, Martha S Bayliss, John E Ware, et al.
Health Technology Assessment (Winchester, England)|May 26, 2011
Prucalopride for the treatment of women with chronic constipation in whom standard laxative regimens have failed to provide adequate reliefM Pennant, R Orlando, P Barton, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Hepatology (Baltimore, Md.)|July 1, 1999
Methods in outcomes research in hepatology: definitions and domains of quality of lifeM S Bayliss
Medical Device Technology|August 8, 2001
Semiconducting biomaterials: current status and future perspectivesL Buckberry, S Bayliss
Health Technology Assessment (Winchester, England)|February 2, 2011
Palivizumab for immunoprophylaxis of respiratory syncytial virus (RSV) bronchiolitis in high-risk infants and young children: a systematic review and additional economic modelling of subgroup analysesD Wang, S Bayliss, C Meads
Health Technology Assessment (Winchester, England)|June 15, 2004
Clinical effectiveness and cost-effectiveness of prehospital intravenous fluids in trauma patientsJ Dretzke, J Sandercock, S Bayliss, et al.
Health and Quality of Life Outcomes|July 8, 2009
The impact of itch symptoms in psoriasis: results from physician interviews and patient focus groupsDenise Globe, Martha S Bayliss, David J Harrison
Health Technology Assessment (Winchester, England)|December 4, 2008
Immunoprophylaxis against respiratory syncytial virus (RSV) with palivizumab in children: a systematic review and economic evaluationD Wang, C Cummins, S Bayliss, et al.
Hepatology (Baltimore, Md.)|July 27, 1999
Health-related quality of life in chronic hepatitis C: impact of disease and treatment response. The Interventional Therapy GroupJ E Ware, M S Bayliss, M Mannocchia, et al.
Seminars in Liver Disease|June 1, 1999
Sustained virologic response is associated with improved health-related quality of life in relapsed chronic hepatitis C patientsM P Neary, S Cort, M S Bayliss, et al.
Health and Quality of Life Outcomes|September 9, 2004
Predicting declines in physical function in persons with multiple chronic medical conditions: what we can learn from the medical problem listElizabeth A Bayliss, Martha S Bayliss, John E Ware, et al.
Health Technology Assessment (Winchester, England)|May 26, 2011
Prucalopride for the treatment of women with chronic constipation in whom standard laxative regimens have failed to provide adequate reliefM Pennant, R Orlando, P Barton, et al.
Pageof 6